Phase I Trial of the Antivascular Agent Combretastatin A4 Phosphate on a 5-Day Schedule to Patients With Cancer: Magnetic Resonance Imaging Evidence for Altered Tumor Blood FlowJames Stevenson, Peter J. O’Dwyer, Daniel G. Haller et al.|Journal of Clinical Oncology|2003Cited by 293
Phase I Trial of Combretastatin A-4 Phosphate with CarboplatinJoshua H. Bilenker, Peter J. O’Dwyer, Keith T. Flaherty et al.|Clinical Cancer Research|2005Cited by 99